ProQR Therapeutics N.V. Ratios

Ratios Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -1,817.39%-2,804.31%-3,874.44%-634.73%-1,931.97%-2,060.05%-624.85%-6,660.47%-857.27%-4,545.47%-1,783.75%-426.97%-147.90%
EBIT Margin -1,817.39%-2,804.31%-3,874.44%-822.76%-1,955.19%-1,910.28%-611.51%-6,758.24%-781.26%-4,285.39%-1,812.99%-489.09%-161.18%
EBITDA Margin -1,817.39%-2,783.62%-3,834.19%0.03%-0.79%2,053.02%-0.47%5.06%-865.83%-4,573.86%-1,742.85%-450.51%-146.58%
Operating Margin -822.76%-1,955.19%-1,910.28%-611.51%-6,758.24%-781.26%-4,285.39%-1,812.99%-489.09%-161.18%
Net Margin -1,817.39%-2,804.31%-3,874.44%-634.73%-1,931.97%-2,058.35%-621.63%-6,644.71%-858.66%-4,549.81%-1,792.54%-431.67%-146.86%
FCF Margin -1,413.04%-2,010.34%-4,618.85%-777.82%-1,816.21%-1,654.34%-485.34%-5,241.18%-884.82%-1,984.72%-1,925.88%309.75%-214.17%
Efficiency
Assets Average 211.40M161.97M164.31M
Equity Average 101.53M56.40M69.70M
Invested Capital 181.83M83.54M61.48M108.14M
Asset Utilization Ratio 0.020.040.12
Leverage & Solvency
Interest Coverage Ratio -53.04-10.52-16.80-12.71-21.85-28.11
Debt to Equity 0.390.100.100.10
Debt Ratio 0.210.040.030.05
Equity Ratio 0.540.390.300.53
Times Interest Earned -53.04-10.52-16.80-12.71-21.85-28.11
Valuation
Enterprise Value 454.27M202.58M114.40M75.29M503.73M427.62M227.12M373.01M179.02M38.17M63.60M
Market Capitalization 202.58M114.40M75.29M503.73M427.62M227.12M599.66M277.00M166.81M223.26M
Return Ratios
Return on Sales -18.17%-28.04%-38.74%-6.35%-19.32%-20.60%-6.25%-66.76%-8.60%-45.54%-17.86%-4.26%-1.47%
Return on Capital Employed -0.35%-0.28%-0.27%
Return on Invested Capital -0.47%-0.38%
Return on Assets -0.31%-0.19%-0.18%
Return on Equity -0.65%-0.53%-0.43%